GIA
MRNA icon

Gladstone Institutional Advisory’s Moderna MRNA Stock Holding History

Gladstone Institutional Advisory’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,926
Closed -$466K – 713
2024
Q2 		$466K Buy
+3,926
New +$497K 0.02% 439
2023
Q4 		– Sell
-2,176
Closed -$225K – 684
2023
Q3 		$225K Buy
2,176
+368
+20% +$41K 0.01% 554
2023
Q2 		$220K Sell
1,808
-150
-8% -$20K 0.01% 584
2023
Q1 		$301K Sell
1,958
-32
-2% -$5.28K 0.02% 522
2022
Q4 		$357K Sell
1,990
-363
-15% -$59.4K 0.03% 465
2022
Q3 		$278K Sell
2,353
-64
-3% -$9.71K 0.02% 517
2022
Q2 		$345K Sell
2,417
-2,863
-54% -$409K 0.03% 478
2022
Q1 		$910K Sell
5,280
-1,707
-24% -$287K 0.06% 309
2021
Q4 		$1.77M Sell
6,987
-401
-5% -$117K 0.14% 200
2021
Q3 		$2.84M Sell
7,388
-858
-10% -$316K 0.28% 101
2021
Q2 		$1.94M Buy
8,246
+6,651
+417% +$1.19M 0.23% 110
2021
Q1 		$209K Sell
1,595
-4,950
-76% -$717K 0.03% 379
2020
Q4 		$684K Sell
6,545
-2,369
-27% -$240K 0.14% 133
2020
Q3 		$631K Sell
8,914
-14,880
-63% -$1.04M 0.15% 126
2020
Q2 		$1.53M Buy
23,794
+14,766
+164% +$809K 0.39% 63
2020
Q1 		$270K Buy
+9,028
New +$208K 0.07% 205

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Gladstone Institutional Advisory's MRNA Position: Q3 2024 in Review

Gladstone Institutional Advisory sold out of Moderna (MRNA) in Q3 2024, closing a stake of 3,926 shares — an estimated $466K sold.

Gladstone Institutional Advisory first reported a position in MRNA in Q1 2020 and held it in 16 quarters. The position peaked at $2.84M in Q3 2021. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • Gladstone Institutional Advisory reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
  • Gladstone Institutional Advisory sold 3,926 Moderna shares in Q3 2024, an estimated $466K.
  • Gladstone Institutional Advisory first reported a position in Moderna in Q1 2020 and held it in 16 quarters.
  • Gladstone Institutional Advisory's Moderna position peaked at $2.84M in Q3 2021.
  • 788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on Gladstone Institutional Advisory's 13F filing for Q3 2024, filed 28 Oct 2024.